Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CEOUsman Azam
CEOUsman Azam
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap61.31M
Market cap61.31M
Price-Earnings ratio-1.48
Price-Earnings ratio-1.48
Dividend yield—
Dividend yield—
Average volume380.79K
Average volume380.79K
High today$0.8197
High today$0.8197
Low today$0.78
Low today$0.78
Open price$0.81
Open price$0.81
Volume133.77K
Volume133.77K
52 Week high$1.99
52 Week high$1.99
52 Week low$0.5406
52 Week low$0.5406
CUE News
Simply Wall St 5d
Is Cue Biopharma Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky...
People also own
Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.